BioSpace News Archive

United Therapeutics Corporation will provide an overview and update on the company’s business during a fireside chat session at the Oppenheimer 33rd Annual Healthcare Conference.

Neovasc Inc. is pleased to announce that its Shareholders (as defined below) have approved the previously-announced acquisition of all of the outstanding common shares of the Company (the “Shares”) by Shockwave Medical, Inc.

Tabula Rasa HealthCare, Inc.® (Nasdaq: TRHC) (“TRHC” or the “Company”), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the fourth quarter and full year ended December 31, 2022.

BioMarin Pharmaceutical Inc. today announced that it received notice this afternoon from the U.S. Food and Drug Administration (FDA) that the agency has extended review of the company’s Biologics License Application (BLA) for ROCTAVIAN™ (valoctocogene roxaparvovec) gene therapy for adults with severe hemophilia A.

announced that on March 2023, the Company has entered into definitive investment agreements with certain accredited investors in a private placement transaction, pursuant to which the investors agreed to subscribe for and purchase, and the Company agreed to issue and sell an aggregate of 16,666,665 newly issued Class A ordinary shares of the Company.

Hyperfine, Inc. announced that it will report financial results for the fourth quarter and full year 2022 on Tuesday, March 21, 2023.

The Muscular Dystrophy Association announced Merit Cudkowicz, MD, MSC, a renowned neurologist and clinical researcher in ALS from Massachusetts General Hospital, will receive the 2023 MDA Legacy Award for Achievement in Clinical Research.

Endo International plc (OTC: ENDPQ) today reported financial results for the fourth-quarter ended December 31, 2022.

Heron Therapeutics, Inc. today announced APONVIE (aprepitant) injectable emulsion, is now commercially available for intravenous (IV) use in adults for the prevention of PONV.

Immunomic Therapeutics, Inc. announced today that it will present at the Supply Chain and Logistics for Cell Therapy Summit, March 7-9 in Boston, MAs.